Related references
Note: Only part of the references are listed.Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer
Quan Zhu et al.
MOLECULAR CELL (2018)
Regulation of the Hippo signaling pathway by ubiquitin modification
Youngeun Kim et al.
BMB REPORTS (2018)
Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability
Youngeun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection
Ruth M. Densham et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection
Ruth M. Densham et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
Disease implications of the Hippo/YAP pathway
Steven W. Plouffe et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Biao Ma et al.
NATURE CELL BIOLOGY (2015)
Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DcAF1-Mediated Inhibition of the Hippo Pathway Kinases Latsl and 2 in the Nucleus
Wei Li et al.
CANCER CELL (2014)
BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks
Nicholas A. Willis et al.
NATURE (2014)
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Ashok R. Venkitaraman
SCIENCE (2014)
Mouse models of BRCA1 and their application to breast cancer research
Jennifer Dine et al.
CANCER AND METASTASIS REVIEWS (2013)
Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2
Feng Yin et al.
CELL (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
The Tumor Suppressor Merlin Controls Growth in Its Open State, and Phosphorylation Converts It to a Less-Active More-Closed State
Ifat Sher et al.
DEVELOPMENTAL CELL (2012)
Inhibition of β-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells
Sachin Verma et al.
BLOOD (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
Quan Zhu et al.
NATURE (2011)
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 tumor-suppressor stability
King Ching Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Samuel F. Bunting et al.
CELL (2010)
Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
Wei Li et al.
CELL (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
BRCA1/BARD1 E3 Ubiquitin Ligase Can Modify Histones H2A and H2B in the Nucleosome Particle
Amit Thakar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2010)
The ubiquitin E3 ligase activity of BRCA1 and its biological functions
Wenwen Wu et al.
Cell Division (2008)
E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages
Devin E. Christensen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Catherine M. Eakin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly
Vladimir Joukov et al.
CELL (2006)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
CX Deng
NUCLEIC ACIDS RESEARCH (2006)
Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination
S Sankaran et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II
LM Starita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mass spectrometric and mutational analyses reveal lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase
H Nishikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ubiquitination and proteasomal degradation the BRCA1 tumor suppressor is regulated during cell cycle progression
AD Choudhury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
BRCA1-dependent ubiquitination of γ-tubulin regulates centrosome number
LM Starita et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein
Y Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
SG Brodie et al.
ONCOGENE (2001)
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
H Ruffner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
CBP/p300 interact with and function as transcriptional coactivators of BRCA1
GM Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
